Recent publications on Cancer

Chubak J, Lund JL. Noncancer comparators in cancer survivorship studies. Cancer. 2022 May 3. doi: 10.1002/cncr.34253. Online ahead of print. PubMed

Abubakar M, Mullooly M, Nyante S, Pfeiffer RM, Aiello Bowles EJ, Cora R, Bodelon C, Butler E, Butcher D, Sternberg L, Troester MA, Weinmann S, Sherman M, Glass AG, de Gonzalez AB, Gierach GL. Mammographic density decline, tamoxifen response, and prognosis by molecular characteristics of estrogen receptor-positive breast cancer. JNCI Cancer Spectr. 2022 May 2;6(3):pkac028. doi: 10.1093/jncics/pkac028. PubMed

Zeng C, Bastarache LA, Tao R, Venner E, Hebbring S, Andujar JD, Bland ST, Crosslin DR, Pratap S, Cooley A, Pacheco JA, Christensen KD, Perez E, Zawatsky CLB, Witkowski L, Zouk H, Weng C, Leppig KA, Sleiman PMA, Hakonarson H, Williams MS, Luo Y, Jarvik GP, Green RC, Chung WK, Gharavi AG, Lennon NJ, Rehm HL, Gibbs RA, Peterson JF, Roden DM, Wiesner GL, Denny JC. Association of pathogenic variants in hereditary cancer genes with multiple diseases. JAMA Oncol. 2022 Jun 1;8(6):835-844. doi: 10.1001/jamaoncol.2022.0373. PubMed

Lowry KP, Callaway KA, Lee JM, Zhang F, Ross-Degnan D, Wharam JF, Kerlikowske K, Wernli KJ, Kurian AW, Henderson LM, Stout NK. Trends in annual surveillance mammography participation among breast cancer survivors from 2004 to 2016.  J Natl Compr Canc Netw. 2022;20(4):379-386.e9. doi: 10.6004/jnccn.2021.7081.  PubMed

Smith RE, Sprague B, Henderson LM, Kerlikowske K, Miglioretti DL, Buist DSM, Wernli KJ, Onega T, Schifferdecker K, Jackson-Nefertiti G, Johnson D, Budesky J, Tosteson ANA. Breast density knowledge in a screening mammography population exposed to density notification. J Am Coll Radiol. 2022 Mar 24:S1546-1440(22)00248-4. doi: 10.1016/j.jacr.2022.02.025 [Epub ahead of print] PubMed

Bowles EJA, Ramin C, Buist DSM, Feigelson HS, Weinmann S, Veiga LHS, Bodelon C, Curtis RE, Vo JB, Berrington de Gonzalez A, Gierach GL. Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016. Breast Cancer Res Treat. 2022 May;193(1):203-216. doi: 10.1007/s10549-022-06561-z. Epub 2022 Mar 11. PubMed

Ryser MD, Lange J, Inoue LYT, O'Meara ES, Gard C, Miglioretti DL, Bulliard JL, Brouwer AF, Hwang ES, Etzioni RB. Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort. Ann Intern Med. 2022 Mar 1. doi: 10.7326/M21-3577. [Epub ahead of print]. PubMed

Ho TH, Bissell MCS, Kerlikowske K, Hubbard RA, Sprague BL, Lee CI, Tice JA, Tosteson ANA, Miglioretti DL. Cumulative probability of false-positive results after 10 years of screening with digital breast tomosynthesis vs digital mammography.  JAMA Netw Open. 2022 Mar 1;5(3):e222440. doi: 10.1001/jamanetworkopen.2022.2440. PubMed

Feigelson HS, Clarke CL, Van Den Eeden SK, Weinmann S, Burnett-Hartman AN, Rowell S, Scott SG, White LL, Ter-Minassian M, Honda SAA, Young DR, Kamineni A, Chinn T, Lituev A, Bauck A, McGlynn EA. The Kaiser Permanente Research Bank Cancer Cohort: a collaborative resource to improve cancer care and survivorship.  BMC Cancer. 2022;22(1):209. doi: 10.1186/s12885-022-09252-6.  PubMed

Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, de Koning HJ, Miglioretti DL, van Ravesteyn NT, Schechter C, Sprague BL, Tosteson ANA, Trentham-Dietz A, Weaver D, Yaffe MJ, Yeh JM, Couch FJ, Hu C, Kraft P, Polley EC, Mandelblatt JS, Kurian AW, Robson ME; Breast Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET), in collaboration with the Breast Cancer Surveillance Consortium (BCSC), and the Cancer Risk Estimates Related to Susceptibility (CARRIERS) Consortium. Breast cancer screening strategies for women with ATM, CHEK2, and PALB2 pathogenic variants: a comparative modeling analysis. JAMA Oncol. 2022 Feb 17. doi: 10.1001/jamaoncol.2021.6204. [Epub ahead of print]. PubMed

Kwan ML, Miglioretti DL, Bowles EJA, Weinmann S, Greenlee RT, Stout NK, Rahm AK, Alber SA, Pequeno P, Moy LM, Stewart C, Fong C, Jenkins CL, Kohnhorst D, Luce C, Mor JM, Munneke JR, Prado Y, Buth G, Cheng SY, Deosaransingh KA, Francisco M, Lakoma M, Martinez YT, Theis MK, Marlow EC, Kushi LH, Duncan JR, Bolch WE, Pole JD, Smith-Bindman R. Quantifying cancer risk from exposures to medical imaging in the Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging (RIC) Study: research methods and cohort profile. Cancer Causes Control. 2022 May;33(5):711-726. doi: 10.1007/s10552-022-01556-z. Epub 2022 Feb 2. PubMed

Weinmann S, Francisco MC, Kwan ML, Bowles EJA, Rahm AK, Greenlee RT, Stout NK, Pole JD, Kushi LH, Smith-Bindman R, Miglioretti DL. Positive predictive value and sensitivity of ICD-9-CM codes for identifying pediatric leukemia.  Pediatr Blood Cancer. 2022 Feb;69(2):e29383. doi: 10.1002/pbc.29383. Epub 2021 Nov 13. PubMed

Grayek E, Yang Y, Fischhoff B, Schifferdecker KE, Woloshin S, Kerlikowske K, Miglioretti DL, Tosteson ANA. A procedure for eliciting women's preferences for breast cancer screening frequency.  Med Decis Making. 2022 Jan 22:272989X211073320. doi: 10.1177/0272989X211073320. [Epub ahead of print]. PubMed

Trinh L, Alibhai SMH, Culos-Reed N, Sabiston CM, Jones JM, Rosenberg DE, Whitehorn A, Bastas D, Faulkner GE. Associations of light physical activity, moderate-to-vigorous physical activity and sedentary behavior with quality of life in men on androgen deprivation therapy for prostate cancer: a quantile regression analysis. J Behav Med. 2022 Aug;45(4):533-543. doi: 10.1007/s10865-022-00285-7. Epub 2022 Jan 21. PubMed

Anderson AW, Marinovich ML, Houssami N, Lowry KP, Elmore JG, Buist DSM, Hofvind S, Lee CI. Independent external validation of artificial intelligence algorithms for automated interpretation of screening mammography: a systematic review. J Am Coll Radiol. 2022 Feb;19(2 Pt A):259-273. doi: 10.1016/j.jacr.2021.11.008. Epub 2022 Jan 20. PubMed

Bell-Brown A, Chew L, Weiner BJ, Strate L, Balmadrid B, Lewis CC, Hannon P, Inadomi JM, Ramsey SD, Issaka R. Operationalizing a rideshare intervention for colonoscopy completion: barriers, facilitators, and process recommendations. Front Health Serv. 1:799816. doi: 10.3389/frhs.2021.799816. PubMed

Archambault AN, Jeon J, Lin Y, Thomas M, Harrison TA, Bishop DT, Brenner H, Casey G, Chan AT, Chang-Claude J, Figueiredo JC, Gallinger S, Gruber SB, Gunter MJ, Guo F, Hoffmeister M, Jenkins MA, Keku TO, Le Marchand L, Li L, Moreno V, Newcomb PA, Pai R, Parfrey PS, Rennert G, Sakoda LC, Lee JK, Slattery ML, Song M, Ko Win A, Woods MO, Murphy N, Campbell PT, Su YR, Lansdorp-Vogelaar I, Peterse EF, Cao Y, Zeleniuch-Jacquotte A, Liang PS, Du M, Corley DA, Hsu L, Peters U, Hayes RB. Risk stratification for early-onset colorectal cancer using a combination of genetic and environmental risk scores: an international multi-center study. J Natl Cancer Inst. 2022 Jan 13:djac003. doi: 10.1093/jnci/djac003. Online ahead of print. PubMed

Kerlikowske K, Chen S, Golmakani MK, Sprague BL, Tice JA, Tosteson ANA, Rauscher GH, Henderson LM, Buist DSM, Lee JM, Gard CC, Miglioretti DL. Cumulative advanced breast cancer risk prediction model developed in a screening mammography population. J Natl Cancer Inst. 2022 Jan 13:djac008. doi: 10.1093/jnci/djac008. [Epub ahead of print]. PubMed

Kariya H, Buist DSM, Anderson ML, Lin J, Gao H, Ko LK, Winer RL. Does mailing unsolicited HPV self-sampling kits to women overdue for cervical cancer screening impact uptake of other preventive health services in a United States integrated delivery system?  Prev Med. 2022 Jan;154:106896. doi: 10.1016/j.ypmed.2021.106896. Epub 2021 Nov 17. PubMed

Liu X, Chubak J, Hubbard RA, Chen Y. SAT: a Surrogate-Assisted Two-wave case boosting sampling method, with application to EHR-based association studies. J Am Med Inform Assoc. 2021 Dec 28:ocab267. doi: 10.1093/jamia/ocab267. [Epub ahead of print]. PubMed